Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Rossari Biotech Ltd - 543213 - Reclassification As Key Managerial Personnel

 Pursuant to Regulation 30 of the Securities and Exchange Board of lndia (SEBI) (Listing Obligations and Disclosure Requirements) Regulation, 2015 ("Listing Regulations"), we hereby informed that based on the recommendation of the Nomination and Remuneration Committee of the Company, the Board of Directors at its meeting held today i.e. Thursday, May 19, 2022 has reclassified Mr. Ketan Sablok, Group-Chief Financial Officer, from Senior Management Personnel to Key Managerial Personnel.
19-05-2022
Bigul

Rossari Biotech Ltd - 543213 - Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, May 19, 2022

 The Board of Directors have Inter alia approved Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2022 of the financial year 2021-22 and other matters
19-05-2022
Bigul

Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Earnings Conference Call for investors and analysts on Monday, May 23, 2022 at 06:00 P.M. IST
18-05-2022
Bigul

Rossari Biotech Ltd - 543213 - Board to consider FY22 Results & Final Dividend on May 19, 2022

 Rossari Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on May 19, 2022, inter alia, to approve the following:1. Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2022.2. To recommend payment of Final Dividend, if any, for the Financial Year ended March 31, 2022.Further, vide the Company''s letter dated March 28, 2022, thd Company had intimated that the "Trading Window" for dealing in securities of the Company, shall remain closed for all the "Designated Persons and their immediate relatives" covered underCompany''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders (Code of Conduct), from April 01, 2022 till 48 hours after the announcement of Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2022.
11-05-2022
Bigul

Rossari Biotech Ltd - 543213 - Board Meeting Intimation for Intimation Of Board Meeting

 Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2022 ,inter alia, to consider and approve Audited Financial Results (Standalone and Consolidated) for the quarter and Financial Year ended March 31, 2022 and Dividend (if any)
11-05-2022
Bigul

Rossari Biotech Ltd - 543213 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayRossari Biotech Ltd 2CINL24100MH2009PLC194818 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY AA- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Parul Gupta Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Manasi Nisal Designation: Chief Financial Officer EmailId: [email protected] Date: 27/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
27-04-2022
Bigul

Rossari Biotech Ltd - 543213 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

 Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Rossari Biotech Ltd 2 CIN NO. L24100MH2009PLC194818 3 Report filed for FY 2021-2022 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* FY 2021-22, 22-23 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)FY 2021-22, 22-23 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Parul GuptaDesignation :-Company Secretary and Compliance Officer Name of the Chief Financial Officer :- Manasi Nisal Designation : -Chief Financial Officer Date: 27/04/2022
27-04-2022
Bigul

Rossari Biotech Ltd - 543213 - Compliance Certificate Under Regulation 7(3) Of Listing Regulations

 Compliance certificate under Regulation 7(3) of Listing Regulations for the year ended March 31, 2022.
13-04-2022
Bigul

Rossari Biotech Ltd - 543213 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Compliance Certificate under Regulation 74 (5) of SEBI (Depository and Participants) Regulations, 2018 for the quarter ended March 31, 2022.
12-04-2022
Bigul

Rossari Biotech Ltd - 543213 - Compliance Certificate Pursuant To Regulation 40 (10)

 Compliance certificate issued by Mr. Sanjay Dholakia of Sanjay Dholakia & Associates, Practicing Company Secretaries, for the period April 01, 2021 to March 31, 2022.
12-04-2022
Next Page
Close

Let's Open Free Demat Account